Bifidobacterium longum 35624

DIETARY_SUPPLEMENT2 trials

Sponsors

Biocodex, Medice Arzneimittel Pütter GmbH & Co KG

Conditions

Irritable Bowel Syndrome

Unknown Phase

Efficacy of Bifidobacterium Longum 35624 on the Quality of Life of IBS Patients With Different Symptom Severity

CompletedNCT04662502

BiocodexIrritable Bowel Syndrome

Start: 2018-11-22End: 2020-06-26Updated: 2021-03-12

Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome

TerminatedNCT04859075

Medice Arzneimittel Pütter GmbH & Co KGIrritable Bowel Syndrome

Start: 2021-05-05End: 2021-11-09Updated: 2022-01-06